← BioTransfer GEO Dataset Finder
GEO series

Benralizumab treatment in patients with severe asthma: A comparative analysis of T-cell gene expression profiles and identification of response-associated genes

GSE290782 Homo sapiens (human) RNA-seq (gene expression) 34 samples Submitted 2025/06/10 Platform GPL20795
At a glance

RNA-seq (gene expression) · human · 34 samples

What it is
RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
Organism
Homo sapiens (human)
Samples
34 samples: 17 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
Data you can get
A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Paper
Identification of potential transcriptomic and microRNA markers to assess benralizumab effectivenessThe Journal of allergy and clinical immunology · 2025
Summary (written by the submitters)
Benralizumab, an antibody that targets the interleukin-5 (IL-5) receptor, suppresses IL-5 activity, which plays a critical role in eosinophil development. Clinical studies have shown its efficacy in reducing eosinophil counts in both the blood and sputum, which has been shown to be beneficial for patients with severe asthma. In this study, we analyzed the gene expression patterns of T cells in 17 patients with severe asthma treated with benralizumab.
Read the full summary ↓
Comparisons were made between baseline (week 0) and post-treatment (week 24) samples. In addition, this study aimed to identify specific genes associated with the treatment response.
Published in
Identification of potential transcriptomic and microRNA markers to assess benralizumab effectiveness
Hirai K, Shirai T, Uehara S et al. · The Journal of allergy and clinical immunology 2025 · PMID 40618854 · doi:10.1016/j.jaci.2025.06.025
This dataset
Download · which file do I need?

Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.

1 · Just have a look

Processed table

The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.

2 · Re-analyse it

Supplementary files

The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE290782_RAW.tar (it can run to tens of gigabytes).

3 · Start from the raw reads

Raw sequencing reads

The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.

What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.

Also filed as BioProject PRJNA1230105 and SRA study SRP567052. Searching any of these in the dataset finder brings you back here.

Study design
17 conditions, mostly in duplicate
Patient 1, Week ×2 Patient 2, Week ×2 Patient 3, Week ×2 Patient 4, Week ×2 Patient 5, Week ×2 Patient 6, Week ×2 Patient 7, Week ×2 Patient 8, Week ×2 +9 more

Supports a between-group comparison across 34 samples.

How we read this: 17 replicated groups read from 34 sample titles; they account for 34 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.

Samples in this study
Datasets on a similar topic

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.